A significant difference between CIAP and GN was seen in only 1 of 136 antigens; GN patients were significantly more likely to show IgM positivity against the GM2:GT1b complex(46.9% vs. 21.4%). This evidence concerns the gene CD40LG and ganglioneuroma.